Izotropic Corp. engages in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. Its initial plan was to complete the engineering of the first imaging device and seek approval in the USA as a diagnostic device for detecting breast cancers. The company was founded by John M. Boone and Robert Louis Thast on May 19, 2016, and is headquartered in Surrey, Canada.